These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 6295261)

  • 1. Direct and specific inactivation of rhinovirus by chalcone Ro 09-0410.
    Ishitsuka H; Ninomiya YT; Ohsawa C; Fujiu M; Suhara Y
    Antimicrob Agents Chemother; 1982 Oct; 22(4):617-21. PubMed ID: 6295261
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative studies on the antirhinovirus activity and the mode of action of the rhinovirus capsid binding agents, chalcone amides.
    Ninomiya Y; Shimma N; Ishitsuka H
    Antiviral Res; 1990 Feb; 13(2):61-74. PubMed ID: 2160796
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antivirus agent, Ro 09-0410, binds to rhinovirus specifically and stabilizes the virus conformation.
    Ninomiya Y; Ohsawa C; Aoyama M; Umeda I; Suhara Y; Ishitsuka H
    Virology; 1984 Apr; 134(2):269-76. PubMed ID: 6100571
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Studies of rhinovirus resistant to an antiviral chalcone.
    Ahmad AL; Dowsett AB; Tyrrell DA
    Antiviral Res; 1987 Aug; 8(1):27-39. PubMed ID: 2825590
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antipicornavirus flavone Ro 09-0179.
    Ishitsuka H; Ohsawa C; Ohiwa T; Umeda I; Suhara Y
    Antimicrob Agents Chemother; 1982 Oct; 22(4):611-6. PubMed ID: 6295260
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular basis of drug resistance to new antirhinovirus agents.
    Ishitsuka H; Ninomiya Y; Suhara Y
    J Antimicrob Chemother; 1986 Oct; 18 Suppl B():11-8. PubMed ID: 3025150
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative studies on the modes of action of the antirhinovirus agents Ro 09-0410, Ro 09-0179, RMI-15,731, 4',6-dichloroflavan, and enviroxime.
    Ninomiya Y; Aoyama M; Umeda I; Suhara Y; Ishitsuka H
    Antimicrob Agents Chemother; 1985 Apr; 27(4):595-9. PubMed ID: 2988431
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathogenicity for humans of human rhinovirus type 2 mutants resistant to or dependent on chalcone Ro 09-0410.
    Yasin SR; al-Nakib W; Tyrrell DA
    Antimicrob Agents Chemother; 1990 Jun; 34(6):963-6. PubMed ID: 2168152
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiviral capsid-binding compounds can inhibit the adsorption of minor receptor rhinoviruses.
    Dewindt B; van Eemeren K; Andries K
    Antiviral Res; 1994 Sep; 25(1):67-72. PubMed ID: 7811059
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of the antirhinovirus chalcone Ro 09-0415 given orally to volunteers.
    Phillpotts RJ; Higgins PG; Willman JS; Tyrrell DA; Lenox-Smith I
    J Antimicrob Chemother; 1984 Oct; 14(4):403-9. PubMed ID: 6094423
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro activity of pirodavir (R 77975), a substituted phenoxy-pyridazinamine with broad-spectrum antipicornaviral activity.
    Andries K; Dewindt B; Snoeks J; Willebrords R; van Eemeren K; Stokbroekx R; Janssen PA
    Antimicrob Agents Chemother; 1992 Jan; 36(1):100-7. PubMed ID: 1317142
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro activity of WIN 51711, a new broad-spectrum antipicornavirus drug.
    Otto MJ; Fox MP; Fancher MJ; Kuhrt MF; Diana GD; McKinlay MA
    Antimicrob Agents Chemother; 1985 Jun; 27(6):883-6. PubMed ID: 2992365
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibitors of picornavirus uncoating as antiviral agents.
    Diana GD; Otto MJ; McKinlay MA
    Pharmacol Ther; 1985; 29(3):287-97. PubMed ID: 3014575
    [No Abstract]   [Full Text] [Related]  

  • 14. Intranasal chalcone, Ro 09-0410, as prophylaxis against rhinovirus infection in human volunteers.
    Al-Nakib W; Higgins PG; Barrow I; Tyrrell DA; Lenox-Smith I; Ishitsuka H
    J Antimicrob Chemother; 1987 Dec; 20(6):887-92. PubMed ID: 3326874
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synergism between anti-rhinovirus antivirals: various human interferons and a number of synthetic compounds.
    Ahmad AL; Tyrrell DA
    Antiviral Res; 1986 Jul; 6(4):241-52. PubMed ID: 3017203
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SDZ 35-682, a new picornavirus capsid-binding agent with potent antiviral activity.
    Rosenwirth B; Oren DA; Arnold E; Kis ZL; Eggers HJ
    Antiviral Res; 1995 Jan; 26(1):65-82. PubMed ID: 7741522
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug targets in rhinoviral infections.
    Rohde G
    Infect Disord Drug Targets; 2009 Apr; 9(2):126-32. PubMed ID: 19275701
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-rhinovirus activity of 3-methylthio-5-aryl-4-isothiazolecarbonitrile derivatives.
    Garozzo A; Cutrì CC; Castro A; Tempera G; Guerrera F; Sarvà MC; Geremia E
    Antiviral Res; 2000 Mar; 45(3):199-210. PubMed ID: 10771083
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanism of action of the antirhinovirus flavanoid 4',6-dicyanoflavan.
    Conti C; Tomao P; Genovese D; Desideri N; Stein ML; Orsi N
    Antimicrob Agents Chemother; 1992 Jan; 36(1):95-9. PubMed ID: 1317152
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiviral activity of flavones and flavans.
    Selway JW
    Prog Clin Biol Res; 1986; 213():521-36. PubMed ID: 3012583
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.